JPRN-UMIN000012722已完成未知
Therapeutic efficacy of budesonide inhalation suspension for moderate bronchial asthma attacks as a substitute for steroid injection - Therapeutic efficacy of budesonide inhalation suspension for bronchial asthma attacks
ational Hospital Organization Sagamihara National Hospital0 个研究点目标入组 100 人开始时间: 2013年12月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The subjects who are diagnosed as respiratory syncytial (RS) virus infection The subjects who require oxygen administration The subjects who are not appropriate for this study, judged by medical doctor
研究者
相似试验
已完成
1 期
Therapeutic effect of inhaled budesonide in transient tachypnea of newborn: A placebo-controlled studyTransient Tachypnea of newborntachypnea ,neonateTCTR20200513005mohamed shawky elfarargy100
已完成
不适用
Evaluation of efficacy of budesonide inhalation suspension for infants with severe intermittent asthma - A multicenter, open, randomized, parallel-group studybronchial asthmaJPRN-UMIN000001557Mie National Hospital80
已完成
不适用
Efficacy of low dose budesonide inhalation suspension / sodium cromoglicate inhalation solution for mild / moderate persistent asthma in young childrebronchial asthmaJPRN-UMIN000003070Mild One research society40
尚未招募
不适用
Clinical trial to study the effect of Budesonide taken through inhalation in mild COVID casesCTRI/2020/10/028581Dr Tushar Patel
进行中（未招募）
1 期
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia - NEUROSISHigh risk of bronchopulmonary dysplasia in very preterm neonatesMedDRA version: 12.1Level: LLTClassification code 10006475Term: Bronchopulmonary dysplasiaEUCTR2009-012203-26-EEniversitätsklinikum Tübingen863